The financial burden of cancer care: do patients in the US know what to expect?

Peppercorn, Jeffrey

doi:10.1586/14737167.2014.963558

Cited by 22 publications

(18 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Conversely, survivors who are unable to meet healthcare expenses may also be proactive in communicating this to their provider and initiating follow-up care discussions for similar reasons. However, these are unlikely explanations given prior research indicating providers’ and patients lack of discussion about costs of care in making decisions about cancer care [19, 20]. Future cancer survivorship research could benefit by examining the role financial hardship plays in delivery of follow-up care in addition to common socioeconomic indicators.…”

Section: Resultsmentioning

confidence: 99%

“…Although insurance has been identified as an important financial factor for receiving high quality cancer treatment, providers and survivors may be unaware of the costs for survivorship care, and patients may move forward with care regardless of payment by the insurer [20]. Additionally, this finding may relate to how MEPS collects data on insurance: Participants are asked their insurance status at the time of the survey, which may not coincide with their cancer episode.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The Relationship Between Cancer Survivors’ Socioeconomic Status and Reports of Follow-up Care Discussions with Providers

DiMartino¹,

Birken²,

Mayer

2016

J Canc Educ

View full text Add to dashboard Cite

Socioeconomically disadvantaged cancer survivors are less likely to have adequate follow-up care. In this study, we examined whether socioeconomically disadvantaged survivors are at risk for not having follow-up care discussions with providers, a critical determinant of access to follow-up care and desirable health outcomes. Using the 2011 Medical Expenditure Panel Survey and Experiences with Cancer Survivorship Supplement, we used a binary logit model with sample weights to examine associations between 1,320 cancer survivors’ socioeconomic status (SES) and reports of follow-up care discussions with providers, controlling for clinical and demographic characteristics. The multivariable model indicated survivors with incomes ≤200% Federal Poverty Level (FPL) had a lower probability of reporting a follow-up care discussion than survivors with incomes >400% FPL (p<.05). Survivors with .05). Socioeconomically disadvantaged cancer survivors are at risk for not having follow-up care discussions with providers, particularly those who report lower income and education. Development of educational interventions targeting provider communication with socioeconomically disadvantaged cancer survivors, and survivors’ understanding of the benefits of follow-up care discussions, may promote access to these services. Future research assessing mechanisms underlying relationships between survivors’ SES indicators and reports of follow-up care discussions with providers is also warranted.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

The Relationship Between Cancer Survivors’ Socioeconomic Status and Reports of Follow-up Care Discussions with Providers

DiMartino¹,

Birken²,

Mayer

2016

J Canc Educ

View full text Add to dashboard Cite

show abstract

“…The reasons for direct non-medical costs have been found to include costs generated from travel and parking, increased household bills, new clothing, healthier food, household-and childcare-related services, fitness classes, relocation, house modifications and family and friends (Amir, Wilson, Hennings, & Young, 2012;Céilleachair et al, 2012;Longo, Fitch, Grignon, & McAndrew, 2016;McGrath, 2016b;Moffatt, Noble, & Exley, 2010;Timmons, Gooberman-Hill, & Sharp, 2013b). Knowledge of the expected costs is crucial for cancer patients to reduce their financial distress (Peppercorn, 2014) because experiencing a higher than expected financial burden has been found to increase experiences of financial distress (Chino et al, 2017). Furthermore, a study analysing the viewpoints of oncology navigators found that they were aware of the high financial burden of their patients but had insufficient knowledge to address this issue (Spencer et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

‘It was a big monetary cut’—A qualitative study on financial toxicity analysing patients’ experiences with cancer costs in Germany

Lueckmann

Schumann

Hoffmann

et al. 2020

Health Soc Care Community

View full text Add to dashboard Cite

Receiving information about expected costs promptly after a cancer diagnosis through psycho‐oncology care or social counselling is crucial for patients to be prepared for the financial impact. Nevertheless, less is known about financial impacts for cancer patients in countries with statutory health insurance. This study aims to explore the full scope of costs that constitute the financial impact of a cancer diagnosis in Germany and to identify the reasons for high financial decline. Semistructured interviews with 39 cancer patients were conducted between May 2017 and April 2018. Narratives were analysed via qualitative content analysis. Several factors influenced cancer patients’ indirect costs and direct medical and non‐medical costs. For many patients, these changes resulted in higher indirect costs caused by income losses, especially when surcharges for shift work, travel expenses or company benefits ceased and were not reimbursed. Higher direct medical costs were caused by co‐payments and additional non‐refundable costs. Non‐medical costs were reported to increase for some patients and to decrease for others, as for example, leisure activity costs either increasing because of pampering oneself to cope with the diagnosis and undergoing therapy or decreasing because of not being able to participate in leisure activities during therapy. When analysing the financial impacts of individuals' total costs, we found that some patients experienced no financial decline or an overall financial increase. Most patients experienced overall higher costs, and income loss was the main driver of a high financial decline. Nevertheless, decreased non‐medical costs due to lower work‐related and leisure activity costs could compensate for these higher costs. Cancer patients are confronted with a variety of changes in their financial situations, even in countries with statutory health insurance. Screening for cancer patients with a high risk of financial decline should consider any effects on indirect costs and direct medical and nonmedical costs.

show abstract

“…Although great strides have been made to localize the dose of radiation to the cancer, normal tissues and organs still often are subjected to a substantial dose of radiation as part of treatment, which can result in significant complications. While radiotherapy is often curative, the adverse effects resulting from treatment can place a major financial burden on both individuals as well as the health care system 10 .…”

Section: Introductionmentioning

confidence: 99%

Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity

Rosenstein

2017

Seminars in Radiation Oncology

View full text Add to dashboard Cite

The overall goal of radiogenomics is the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation. The principal rationale for a focus on toxicity in radiogenomics is that for many patients treated with radiation, especially individuals diagnosed with early stage cancers, the survival rates are high and therefore a substantial number of people will live for a significant period of time beyond treatment. However, many of these patients could suffer from debilitating complications resulting from radiotherapy. Work in radiogenomics has greatly benefited from creation of the Radiogenomics Consortium (RGC), which includes investigators at multiple institutions located in a variety of countries. The common goal of the RGC membership is to share biospecimens and data so as to achieve large scale studies with increased statistical power to enable identification of relevant genomic markers. A principal aim of research in radiogenomics is the development of a predictive instrument to enable identification of people who are at greatest risk for adverse effects resulting from cancer treatment using radiation. It is anticipated that creation of a predictive assay characterized by a high level of sensitivity and specificity will improve precision radiotherapy and assist patients and their physicians to select the optimal treatment for each individual.

show abstract

The financial burden of cancer care: do patients in the US know what to expect?

Cited by 22 publications

References 53 publications

The Relationship Between Cancer Survivors’ Socioeconomic Status and Reports of Follow-up Care Discussions with Providers

The Relationship Between Cancer Survivors’ Socioeconomic Status and Reports of Follow-up Care Discussions with Providers

‘It was a big monetary cut’—A qualitative study on financial toxicity analysing patients’ experiences with cancer costs in Germany

Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity

Contact Info

Product

Resources

About